S160P (p.Ser160Pro) variant of SATB2 (DNA-binding protein SATB2)
S160P (p.Ser160Pro) in SATB2 (DNA-binding protein SATB2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes structural context.
S160P (p.Ser160Pro) variant details
- p.Ser160Pro
- NCI-TCGA Cosmic COSV5349
- cosmic curated COSV53493
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.262
- ESM-1b 0.00
- AlphaMissense 0.15
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available